Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA)

British Journal of Cancer

Volumn 101, Issue 12, 2009, Pages 2048-2054

  Osorio, A ^a   Milne, R L ^a   Pita, G ^a   Peterlongo, P ^b,c   Heikkinen, T ^d   Simard, J ^e   Chenevix Trench, G ^f   Spurdle, A B ^f   Beesley, J ^f   Chen, X ^f   Healey, S ^g   Neuhausen, S L ^h   Ding, Y C ^h   Couch, F J ⁱ   Wang, X ⁱ   Lindor, N ⁱ   Manoukian, S ^b   Barile, M ^j   Viel, A ^k   Tizzoni, L ^c,l   Szabo, C I ^m   Foretova, L ⁿ   Zikan, M ^o   Claes, K ^p   Greene, M H ^q   Mai, P ^q   Rennert, G ^r   Lejbkowicz, F ^r   Barnett Griness, O ^r   Andrulis, I L ^s,t   Ozcelik, H ^t   Weerasooriya, N ^s   Gerdes, A M ^u   Thomassen, M ^u   Cruger, D G ^v   Caligo, M A ^w   Friedman, E ^x,y   Kaufman, B ^x,y   Laitman, Y ^x   Cohen, S ^x   Kontorovich, T ^x   Gershoni Baruch, R ^z   Dagan, E ^aa,ab   Jernstrom H ^ac   Askmalm, M S ^ad   Arver, B ^ae   Malmer, B ^af   Domchek, S M ^ag   Nathanson, K L ^ag   Brunet, J ^ah   Ramon Y Cajal T ^ai   Yannoukakos, D ^aj   Hamann, U ^ak   Hogervorst, F B L ^al   Verhoef, S ^al   Garcíla, E B Gómez ^am,an   Wijnen, J T ^ao   Van Den Ouweland, A ^ap   Easton, D F ^aq   Peock, S ^aq   Cook, M ^aq   Oliver, C T ^aq   Frost, D ^aq   Luccarini, C ^aq   Evans, D G ^ar   Lalloo, F ^ar   Eeles, R ^as   Pichert, G ^at   Cook, J ^au   Hodgson, S ^av   Morrison, P J ^aw   Douglas, F ^ax   Godwin, A K ^ay,az,ba,bb   Sinilnikova, O M ^az,ba   Barjhoux, L ^az,ba   Stoppa Lyonnet, D ^bb   Moncoutier, V ^bb   Giraud, S ^az   Cassini, C ^bc,bd   Olivier Faivre, L ^bc,bd   Revillion F ^be   Peyrat, J P ^be   Muller, D ^bf   Fricker, J P ^bf   Lynch, H T ^bg   John, E M ^bh   Buys, S ^bi   Daly, M ^ay   Hopper, J L ^bj   Terry, M B ^bk   Miron, A ^bl   Yassin, Y ^bl   Goldgar, D ^bm   Singer, C F ^bn   Gschwantler Kaulich, D ^bn   Pfeiler, G ^bn   Spiess, A C ^bn   Hansen, Thomas V O ^u   Johannsson, O T ^bo   Kirchhoff, T ^bp   Offit, K ^bp   Kosarin, K ^bp   Piedmonte, M ^bq   Rodriguez, G C ^br   Wakeley, K ^bs   Boggess, J F ^bt   Basil, J ^bu   Schwartz, P E ^bv   Blank, S V ^bw   Toland, A E ^bx   Montagna, M ^by   Casella, C ^bf   Imyanitov, E N ^bz   Allavena, A ^ca   Schmutzler, R K ^cb   Versmold, B ^cc   Engel, C ^cd   Meindl, A ^ce   Ditsch, N ^cf   Arnold, N ^cf   Niederacher, D ^cg   Deiler, H ^ch   Fiebig, B ^ci   Varon Mateeva, R ^cj   Schaefer, D ^ck   Froster, U G ^cc   Caldes, T ^cl   De La Hoya, M ^cl   McGuffog, L ^aq   Antoniou, A C ^aq   Nevanlinna, H ^d   Radice, P ^b,c   Benitez J ^a   more..

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITÉ LAVAL   (Canada)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g PETER MACCALLUM CANCER CENTRE   (Australia)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ MAYO CLINIC   (United States)

^j EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^k CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^l IRCCS ^*  (Italy)

^m Mayo Clinic   (United States)

ⁿ MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^o CHARLES UNIVERSITY   (Czech Republic)

^p GHENT UNIVERSITY HOSPITAL   (Belgium)

^q NATIONAL CANCER INSTITUTE   (United States)

^r CARMEL MEDICAL CENTER   (Israel)

^s CANCER CARE ONTARIO   (Canada)

^t MOUNT SINAI HOSPITAL   (Canada)

^u ODENSE UNIVERSITY HOSPITAL   (Denmark)

^v LILLEBAELT HOSPITAL   (Denmark)

^w UNIVERSITY HOSPITAL OF PISA   (Italy)

^x SHEBA MEDICAL CENTER   (Israel)

^y TEL AVIV UNIVERSITY   (Israel)

^z RAMBAM MEDICAL CENTER   (Israel)

^aa UNIVERSITY OF HAIFA   (Israel)

^ab Institute of Human Genetics   (Israel)

^ac LUND UNIVERSITY   (Sweden)

^ad LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^ae KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^af UMEÅ UNIVERSITY   (Sweden)

^ag UNIVERSITY OF PENNSYLVANIA   (United States)

^ah CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ai HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^aj IRRP   (Greece)

^ak GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^al NETHERLANDS CANCER INSTITUTE   (United States)

^am MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^an Research Institute Growth and Development (GROW)   (United States)

^ao LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ap ERASMUS MEDICAL CENTER   (Netherlands)

^aq UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ar ST MARY S HOSPITAL   (United Kingdom)

^as INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^at GUY S HOSPITAL   (United Kingdom)

^au SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^av ST GEORGE S HOSPITAL   (United Kingdom)

^aw BELFAST CITY HOSPITAL   (United Kingdom)

^ax NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^ay FOX CHASE CANCER CENTER   (United States)

^az HOSPICES CIVILS DE LYON   (France)

^ba UNIVERSITÉ DE LYON   (France)

^bb INSERM   (France)

^bc HÔpital d'enfant   (France)

^bd CLCC Georges Francois Leclerc   (France)

^be CENTRE OSCAR LAMBRET   (France)

^bf Centre Oscar Lambret ^*  (Italy)

^bg CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bh NORTHERN CALIFORNIA CANCER CENTER   (United States)

^bi UNIVERSITY OF UTAH   (United States)

^bj UNIVERSITY OF MELBOURNE   (Australia)

^bk Och Spine at New York Presbyterian Hospitals   (United States)

^bl DANA FARBER CANCER INSTITUTE   (United States)

^bm UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^bn MEDICAL UNIVERSITY OF VIENNA   (Austria)

^bo LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^bp MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^bq ROSWELL PARK CANCER INSTITUTE   (United States)

^br NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^bs TUFTS UNIVERSITY   (United States)

^bt UNIVERSITY OF NORTH CAROLINA   (United States)

^bu St Elizabeth Medical Center   (United States)

^bv YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bw NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bx OHIO STATE UNIVERSITY   (United States)

^by VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^bz N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^ca UNIVERSITY OF TURIN   (Italy)

^cb UNIVERSITY OF COLOGNE   (Germany)

^cc UNIVERSITY OF LEIPZIG   (Germany)

^cd TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ce UNIVERSITY OF MUNICH   (Germany)

^cf UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^cg HEINRICH HEINE UNIVERSITY   (Germany)

^ch UNIVERSITY OF ULM   (Germany)

^ci UNIVERSITY OF REGENSBURG   (Germany)

^cj HUMBOLDT UNIVERSITY   (Germany)

^ck GOETHE UNIVERSITY   (Germany)

^cl HOSPITAL CLÍNICO SAN CARLOS   (Spain)

more..

Author keywords

BRCA1; BRCA2; Breast cancer; ERCC4

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; ERCC4 GENE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 71649085141     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605416     Document Type: Article

References (19)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130
2. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, Easton DF (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29: 1-11
3. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kampjarvi K, Nevanlinna H, Simard J, Beesley J, Chen X, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Blum JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Pereira LH, Greene MH, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Gerdes AM, Caligo MA, Laitman Y, Kaufman B, Milgrom R, Friedman E, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benitez J, Hamann U, Hogervorst FB, Manders P, Ligtenberg MJ, van den Ouweland AM, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Bressac-de Paillerets B, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D, Chenevix-Trench G, Easton DF (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82: 937-948
4. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24: 863-871
5. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9: 104
6. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265-271
7. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093 (Pubitemid 47014426)
8. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689
9. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardon A, Serra C, Carrato A, Garcia-Closas R, Castano-Vinyals G, Chanock S, Yeager M, Rothman N (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15: 536-542
10. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kampjarvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schurmann P, Dork T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M (2009) Five polymorphisms and breast cancer risk: results from the breast cancer association consortium. Cancer Epidemiol Biomarkers Prev 18: 1610-1616
11. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA (2008) NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis 11: 349-356
12. Kiyohara C, Yoshimasu K (2007) Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 4: 59-71
13. Lange K, Weeks D, Boehnke M (1988) Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5: 471-472
14. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Tse CK, Keku T (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27: 1377-1385
15. Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Diez O, Alonso MC, Lazaro C, Blanco I, Sanchez-de-Abajo A, Caldes T, Blanco A, Grana B, Duran M, Velasco E, Chirivella I, Cardenosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martinez E, Guillen C, Salazar R, San Roman C, Antoniou AC, Urioste M, Benitez J (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14: 2861-2869
16. Milne RL, Ribas G, Gonzalez-Neira A, Fagerholm R, Salas A, Gonzalez E, Dopazo J, Nevanlinna H, Robledo M, Benitez J (2006) ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res 66: 9420-9427
17. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, Gonzalez S, Guino E, Capella G, Canzian F (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12: 2101-2108
18. Osorio A, Martinez-Delgado B, Pollan M, Cuadros M, Urioste M, Torrenteras C, Melchor L, Diez O, De La Hoya M, Velasco E, Gonzalez-Sarmiento R, Caldes T, Alonso C, Benitez J (2006) A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat 27: 242-248
19. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138